| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Virpax Pharmaceuticals, Inc. | Chief Executive Officer, Director | Stock Option (right to buy) | 125,000 | 29 Jan 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VRPX | Virpax Pharmaceuticals, Inc. | 29 Jan 2024 | 1 | $0 | 4 | Chief Executive Officer, Director | 31 Jan 2024, 16:22 |
| VRPX | Virpax Pharmaceuticals, Inc. | 24 Apr 2023 | 1 | $0 | 4 | Director | 26 Apr 2023, 21:00 |
| VRPX | Virpax Pharmaceuticals, Inc. | 25 Apr 2022 | 1 | $0 | 4 | Director | 27 Apr 2022, 18:00 |
| VRPX | Virpax Pharmaceuticals, Inc. | 26 Jul 2021 | 0 | $0 | 3 | Director | 05 Aug 2021, 18:04 |